Showing 18,801 - 18,820 results of 102,951 for search '(( a web decrease ) OR ( 5 ((point decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 1.57s Refine Results
  1. 18801

    End Stage Renal Disease Predicts Increased Risk of Death in First Degree Relatives in the Norwegian Population by Rannveig Skrunes (3339708)

    Published 2016
    “…Excluding known hereditary renal disease, aHR decreased to 1.12 (1.09–1.15). Cardiovascular death aHR was 1.15 (1.10–1.21), of which cerebrovascular death 1.34 (1.22–1.50). aHR for death due to non-hereditary renal/ureteric disease was 2.29 (1.81–2.91) with renal failure 1.80 (1.26–2.56) and glomerular disease 5.69 (3.88–8.34) as main contributors. …”
  2. 18802
  3. 18803
  4. 18804

    Reduction Pathway of End-On Terminally Coordinated Dinitrogen. IV. Geometric, Electronic, and Vibrational Structure of a W(IV) Dialkylhydrazido Complex and Its Two-Electron-Reduced... by Kay H. Horn (2684512)

    Published 2005
    “…The molybdenum and tungsten dialkylhydrazido complexes [M(dppe)<sub>2</sub>(NNC<sub>5</sub>H<sub>10</sub>)]<sup>2+</sup> (M = Mo, W; compounds <b>A</b><sup>Mo</sup> and <b>A</b><sup>W</sup>) and their two-electron-reduced counterparts [M(dppe)<sub>2</sub>(NNC<sub>5</sub>H<sub>10</sub>)] (compounds <b>B</b><sup>Mo</sup> and <b>B</b><sup>W</sup>) are characterized structurally and spectroscopically. …”
  5. 18805
  6. 18806

    Detection of Proteome Changes in Human Colon Cancer Induced by Cell Surface Binding of Growth-Inhibitory Human Galectin‑4 Using Quantitative SILAC-Based Proteomics by Malwina Michalak (505581)

    Published 2016
    “…The strongest induction was found for CALB2 (calretinin; ∼24-fold), TGM2 (protein-glutamine γ-glutamyltransferase 2; ∼11-fold), S100A3 (∼10-fold), and GSN (gelsolin; 9.5-fold), and the most pronounced decreases were seen for CDKN2A (tumor suppressor ARF; ∼6-fold), EPCAM (epithelial cell adhesion molecule; ∼6-fold), UBE2C (ubiquitin-conjugating enzyme E2 C; ∼5-fold), KIF2C (kinesin-like protein KIF2C; 5-fold), and LMNB1 (lamin-B1; ∼5-fold). …”
  7. 18807

    Detection of Proteome Changes in Human Colon Cancer Induced by Cell Surface Binding of Growth-Inhibitory Human Galectin‑4 Using Quantitative SILAC-Based Proteomics by Malwina Michalak (505581)

    Published 2016
    “…The strongest induction was found for CALB2 (calretinin; ∼24-fold), TGM2 (protein-glutamine γ-glutamyltransferase 2; ∼11-fold), S100A3 (∼10-fold), and GSN (gelsolin; 9.5-fold), and the most pronounced decreases were seen for CDKN2A (tumor suppressor ARF; ∼6-fold), EPCAM (epithelial cell adhesion molecule; ∼6-fold), UBE2C (ubiquitin-conjugating enzyme E2 C; ∼5-fold), KIF2C (kinesin-like protein KIF2C; 5-fold), and LMNB1 (lamin-B1; ∼5-fold). …”
  8. 18808
  9. 18809
  10. 18810
  11. 18811
  12. 18812

    Mean and two standard deviations from LNA versus stochastic simulations for Lotka-Volterra model. by Christoph Zimmer (3095667)

    Published 2016
    “…The lower row shows p-values of a Kolmogorov-Smirnov test for each time point whether the 100 stochastic simulations follow a normal distribution with mean and variance from a LNA. …”
  13. 18813
  14. 18814

    Ferroelectricity and a 1/3-Magnetization Plateau in the Polar Magnet LiFeV<sub>2</sub>O<sub>7</sub> with Fe<sup>3+</sup> Ions in a Twisted Diamond Chain by Ravi Shankar P N (9740817)

    Published 2025
    “…LiFeV<sub>2</sub>O<sub>7</sub> crystallizes in a polar monoclinic <i>Cc</i> structure, where Fe<sup>3+</sup> (<i>S</i> = 5/2) ions form diamond chains along the [101] direction, each surrounded by four neighboring chains. …”
  15. 18815
  16. 18816
  17. 18817

    Data Sheet 1_Impact of the SARS-COV-2 pandemic on access to health services in Angola: a focus on diagnosis and treatment services for tuberculosis.docx by Susanna Caminada (16789893)

    Published 2025
    “…</p>Results<p>There was a significant decline in access to TB services during the pandemic, with a substantial decrease in reported cases (−15.5% in 2020; −18.3% in 2021) and treatment rate (from 86% in 2019 to 68% in 2020), an increase in multidrug-resistant-TB (from 0.2% in 2018 to 2.1% in 2022) and TB/HIV co-infections (from 6% in 2018 to 8.8% in 2021). …”
  18. 18818
  19. 18819
  20. 18820